Home health stocks dipped in October as the industry braced for the then-forthcoming home health groupings model (HHGM) decision, according to the Home Health Index November update from M&A advisory firm Stoneridge Partners. The decision ultimately fell in favor of the home health industry. The Centers for Medicare & Medicaid Services (CMS) released its final rule on […]
In the wake of the final 2018 payment rule for home health being released, public companies have seen their stocks skyrocket. The Centers for Medicare & Medicaid Services (CMS) released its prospective payment system (PPS) 2018 update final rule on Wednesday without the inclusion of the home health groupings model (HHGM)—a proposed model that would […]
Only nine publicly announced home health deals occurred in the second quarter of 2017, according to research conducted by Norwalk, Connecticut-based Irving Levin Associates. This performance signified a 40% drop in activity when compared to the total publicly announced mergers and acquisitions in the first quarter of the year (15), as well as a back-to-back decline in […]
Despite experiencing a “hot streak” in the first half of the year, home health care companies saw sharp dives in share values in July, due in large part to investors’ reactions to the Centers for Medicare & Medicaid Services’ (CMS) proposed home health groupings model (HHGM). Three of the largest publicly traded home health care […]
Home health companies once again saw market gains in May, according to the latest Home Health Index tracked by Stoneridge Partners. The home health index, which tracks the stock prices of Amedisys (Nasdaq: AMED), Almost Family (Nasdaq: AFAM) and LHC Group (Nadaq: LHCG), rose 9.1% in May from the previous month. Year to date, the […]
Three of the biggest publicly-traded home health companies had a stellar showing last month, as their market performance both outpaced the S&P 500 index and achieved a new record high for the month of April, according to the latest Home Health Index from Stoneridge Partners. The Home Health Index, which tracks the market values of […]
Three of the largest publicly-traded home health care companies grew their averaged share prices at a modest pace last month, according to the latest Home Health Index released by Stoneridge Partners. The index, which tracks the market values of Almost Family (Nasdaq: AFAM), Amedisys Inc. (Nasdaq: AMED) and LHC Group (Nasdaq: LHCG), ticked up 1.77% in March […]
After three of the largest publicly-traded home health care companies saw their share prices soar in January, the market rally continued in February at a more modest pace, according to the most recent Home Health Index by Stonebridge Partners. The index, which tracks the market values for Almost Family (Nasdaq: AFAM), Amedisys Inc. (Nasdaq: AMED) […]
In a month marked by the inauguration of President Donald Trump, three of the largest publicly-traded home health care companies saw their market values jump, according to the latest Home Health Index by Stoneridge Partners. The jump mirrors the boost that occurred in other indices across the economy, in a phenomenon that’s been dubbed the “Trump rally.” The […]
The market values of the three largest publicly traded home health care companies continued to rise in December, according to the latest Home Health Index by Stoneridge Partners. The index, which tracks the market values of Almost Family (Nasdaq: AFAM), Amedisys (Nasdaq: AMED) and LHC Group (Nasdaq: LHCG), rose 5.42% in December from the previous […]
By continuing to use the site, you agree to the use of cookies. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. For more information, see our cookie policy
